The Journal of
Clinical Psychiatry

Depression (MDD)

Original Research April 1, 2002

Somatic Symptoms, Depression, and Antidepressant Treatment

Maurizio Fava

J Clin Psychiatry 2002;63(4):305-307

Article Abstract

Commentary: Somatic Symptoms, Depression, and Antidepressant Treatment.

Buy PDF for $40.00

Please sign in or purchase this PDF for $40.00.

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 85 • 2024 • Number 4

Read the Current Issue

Meta-Analysis

Changes in Cognition in Patients With Schizophrenia

Systematic Review

Diagnostic Assessment via Telehealth vs Face-to-Face

Original Research

Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans

Original Research

Bridge Symptoms Between Borderline Personality and PTSD

Original Research

Gepirone-ER and Sexual Function in Patients with MDD

Original Research

Medication Use and Lines of Treatment in Patients With Insomnia Disorder

View current Issue

Original Research

Sex Differences in Antidepressant Acceptability

December 4, 2024

This study provides evidence of sex differences in antidepressant acceptability, with fluoxetine more acceptable for men than women and the reverse true for paroxetine. Findings suggest the importance of...

Charles Ouazana Vedrines , Nicolas Hoertel , Thomas Lesuffleur , et al

Original Research

MDD and Bipolar Disorder in Black and White Postpartum Women

November 20, 2024

No significant difference was observed in the rate of postpartum MDD in Black (40%) versus white (35%) women. However, bipolar disorder significantly differed between Black (19.2%) and white (11.5%)...

Taylor N. Burchfield , Amy Yang , Katherine L. Wisner , et al

Original Research

Mixed Features and Suicide Risk in Individuals With Major Depressive Episode

November 6, 2024

In a large sample of the French population, mixed features were linked to a higher risk of suicide attempts in patients with a major depressive episode.

Hugo Peyre , Nicolas Hoertel , Baptiste Pignon , et al

Somatic Symptoms, Depression, and Antidepressant Treatment

Read the Current Issue

Changes in Cognition in Patients With Schizophrenia

Diagnostic Assessment via Telehealth vs Face-to-Face

Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans

Bridge Symptoms Between Borderline Personality and PTSD

Gepirone-ER and Sexual Function in Patients with MDD

Medication Use and Lines of Treatment in Patients With Insomnia Disorder

ELSEWHERE:

FOLLOW US:

Somatic Symptoms, Depression, and Antidepressant Treatment

Read the Current Issue

Changes in Cognition in Patients With Schizophrenia

Diagnostic Assessment via Telehealth vs Face-to-Face

Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans

Bridge Symptoms Between Borderline Personality and PTSD

Gepirone-ER and Sexual Function in Patients with MDD

Medication Use and Lines of Treatment in Patients With Insomnia Disorder

Related Articles

Sex Differences in Antidepressant Acceptability

MDD and Bipolar Disorder in Black and White Postpartum Women

Mixed Features and Suicide Risk in Individuals With Major Depressive Episode

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles